SAR - Profile Therapeutics
28 July 2003 - 9:23PM
UK Regulatory
RNS Number:0182O
3i Investments PLC
28 July 2003
FORM SAR 5
Lodge with Company Announcements Office and the Panel.
A copy must also be sent to the company the shares of which are being sold.
Date of disclosure
28.07.03
DISCLOSURE UNDER NOTE 3 OF RULE 5 OF THE RULES GOVERNING SUBSTANTIAL
ACQUISITIONS OF SHARES ("SARs")
Date of sale
25.07.03
Sale of (name of company)
Profile Therapeutics plc
1. Class of voting shares (eg ordinary shares)
Ordinary 2p shares
Number of shares/rights over shares sold
250,000 Shares Rights
If rights over shares sold, as opposed to the shares themselves, specify nature
of rights
2. Resultant total holding of voting shares (and % of total voting shares in
issue)
10,241,384 20.84 %
Resultant total holding of rights over shares (and % of total voting shares in
issue)
%
Total percentage
20.84 %
3. Party making disclosure
3i Investments plc
4. (a) Name of person selling shares or rights over shares
3i Investments plc
and, if different, beneficial owner
(b) Names of any other persons acting by agreement or understanding
Signed, for and on behalf of the party named in (3) above
(Also print name of signatory)
Simon Howard
Telephone and extension number
020 7928 3131
For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SADILFLLDDITFIV